Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation
Kirk M. Chan‐Tack, Patrick R. Harrington, Timothy J. Bensman, Suyoung Choi, Eric Donaldson, Julian J. O’Rear, David McMillan, L. Peyton Myers, Mark Seaton, Hanan Ghantous, Yu Cao, Thamban Valappil, Debra Birnkrant, Kimberly Struble
Topics & Concepts
Food and drug administrationSmallpoxGovernment (linguistics)MedicineCountermeasureDrug approvalAdministration (probate law)BiodefenseDrug developmentRegulatory affairsRegulatory scienceBusinessPolitical scienceEnvironmental healthDrugPublic administrationVirologyPharmacologyEngineeringLawAerospace engineeringLinguisticsVaccinationPhilosophyPathologyPoxvirus research and outbreaksViral gastroenteritis research and epidemiologyVirus-based gene therapy research